Corient Private Wealth’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
SCM
RCM
PCM
Corient Private Wealth's BMEZ Position: Q2 2026 in Review
Corient Private Wealth opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q2 2026: 30,442 shares worth $467K. The stake represents ﹤0.01% of the portfolio and ranks #2269 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in BMEZ as recently as Q4 2025.
Corient Private Wealth first reported a position in BMEZ in Q4 2022 and has held it in 12 quarters since. The position peaked at $893K in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.
- Corient Private Wealth held 30,442 shares of BlackRock Health Sciences Trust II worth $467K as of Q2 2026.
- BlackRock Health Sciences Trust II was a new Corient Private Wealth position in Q2 2026.
- BlackRock Health Sciences Trust II made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2269 holding.
- Corient Private Wealth first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and has held it in 12 quarters since.
- Corient Private Wealth's BlackRock Health Sciences Trust II position peaked at $893K in Q1 2024.
- 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.